Home » Newsletters » BioWorld Science

BioWorld Science

May 24, 1999

View Archived Issues

Synthetic Blood, Nitric Oxide Solutions team up for development of NO delivery technology

Ipratropium bromide may improve sleep, nocturnal oxygen in COPD patients

SangStat and Abbott sign collaborative agreement for SangCya

FDA clears phase III trial of Cerus's FFP pathogen inactivation system

Phase I trial of Biojector 2000 to deliver malaria DNA vaccine

Risperidone may reduce risk of relapse in schizophrenia

MediGene discovers target gene for DCM therapy

Ligand: Q1 1999 highlights

Betathine trial progressing well

Celltech: interim report October 1998-March 1999

OSI and Pfizer enter license agreement to develop psoriasis treatment

Vivus signs registration and marketing agreement in Japan for Muse

Compounds for promoting hair growth or regrowth disclosed by Shiseido

Early studies indicate efficacy of thalidomide in Crohn's disease

Compounds in development at Shionogi reverse oncogene-induced cell transformation

Calcium channel antagonists from Ajinomoto especially useful in IBS

Yoshitomi reports potent and selective tryptase inhibitors with oral activity

News from DDW: rhIL-10 in treatment of Crohn's disease

The NO-coupled NSAID HCT-1026 does not cause duodenal injury in rat model

Phogen receives further funding from Cantab and Marie Curie Cancer Care for VP22 technology

Cholera vaccine CVD103HgR-pDA60 is an excellent candidate for human studies

Isolex cell selection system receives approval from Health Canada

MMP inhibitor MMI-270 tested in cancer patients in combination with 5-FU/folinic acid

FDA advisory panel review of Levulan to be rescheduled

Tibetan herbal compound is effective in treating symptoms of IBS

Xenova: Q1 1999 highlights

Merck researchers describe L-783281, a novel antidiabetic agent of fungal origin

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...